Elliott Lichtstein, MD

Cardiac Services Cardiology Interventional Cardiology
VMG - Cardiology, Westwood
333 Old Hook Road
Suite 200
Westwood, NJ 07675
(201) 664-0201
VMG - Cardiology, Hackensack
20 Prospect Avenue
Suite 810
Hackensack, NJ 07601
(201) 342-7727
Board Certification
American Board of Internal Medicine, American Board of Interventional Cardiology, Subspecialty Board of Cardiovascular Disease
Undergraduate Education
University of Rochester
Medical Education
Temple University School of Medicine
Residency
Albany Medical Center
Fellowship
Long Island Jewish-Hillside Medical Center
What are some of the specific conditions you treat? Coronary artery disease, myocardial infarction, atrial fibrillation, congestive heart failure, palpitations, hypertension, arrhythmias, pacemaker management, edema, aortic valve disease, mitral valve disease, mitral valve prolapse, aortic aneurysm, PAD-peripheral artery disease, lipid disorders, elevated cholesterol.
What techniques or procedures do you use in your practice? We care for our patients with the latest techniques in cardiac diagnosis including noninvasive and invasive modalities.
Describe some of your professional highlights. Fellow of the American College of Cardiology.
Board certified in internal medicine, cardiovascular diseases.
Board certified in invasive cardiology.
Clinical Trials

Fourier
A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing the Impact of Additional LDL-Cholesterol Reduction on Major Cardiovascular Events When Evolocumab is Used in Combination With Statin Therapy In Patients With Clinically Evident Cardiovascular Disease.

Odyssey
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of Alirocumab on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome.

Cardiovascular Inflammation Reduction Trial (CIRT)
The Cardiovascular Inflammation Reduction Trial (CIRT) is a randomized clinical trial investigating whether taking lowdose methotrexate reduces heart attacks, strokes, or death in people with type 2 diabetes or metabolic syndrome that have had a heart attack or multiple coronary blockages. This trial is funded by the National Heart, Lung, and Blood Institute (NHLBI)/National Institutes of Health (NIH).



 
"Dr. Lichtstein is caring, welcoming and always clearly explains situations. He is bright and listens to what the patient describes."
"Dr. Lichtstein is one of the nicest doctors I've been to. He never rushes you, explains everything, gives good advise and is truly interested in you as a person. My favorite doctor!"
"Dr. Lichtstein is an outstanding doctor. He takes time to truly listen to my concerns. I almost never leave his office with unanswered questions."
"Dr. Lichtstein has been my cardiac doctor for several years and took very good care of my mother.  He is a very knowledgeable, friendly and caring physician. Excellent!"